Patient P-01579
Therapy response
Stable
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Stable
Discontinuation risk
39%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S15
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+11
- Treatment adherence-11
- Toxicity+8
- Inflammatory activity+7
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion29.7/100
worsening · +4.3 vs previous 14 d
Toxicity
Blood27.4/100
worsening · +7.7 vs previous 14 d
Sleep quality
Wearable26/100
improving · +2.6 vs previous 14 d
Energy level
Daily log3.9/10
stable · -0.2 vs previous 14 d
Stress level
Daily log5.7/10
worsening · +0.3 vs previous 14 d
Steps
Wearable3,129
worsening · -311 vs previous 14 d
Adherence
Companion82.4 %
stable · -2.0 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 59 from the failing basin, 30 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More fibreGI -2.9 next day on high-intake days · n 18
Would not help
- Nothing clearly counter-productive in the record.
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Insoluble fibre-2.9supporter · 66%
- Histamine load-2.1no signal · 37%
- Alcohol+1.6no signal · 35%
- Spicy / capsaicin+0.8no signal · 15%
- Simple carbohydrates+0.6no signal · 15%
- Dietary fat load-0.5no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓40
- Wearable3,129 steps/day
- WearableShort sleep window
- Inflammatory signalling ↑35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 32 ms, trending down
- Mucosal barrier integrity ↓10
- WearableSleep 5.4 h, below personal baseline
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.3 · butyrate capacity 49/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 32 ms
- Sleep
- 5.9 h
- Steps
- 3,480
- Resting HR
- 71 bpm
Daily log: GI score 30, nutritional resilience 60, adherence 82.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01804 | 45% | S19 | AD-05 | improved | 61 |
| P-01679 | 36% | S12 | AD-05 | no change | 39 |
| P-01541 | 34% | S09 | AD-05 | no change | 43 |
| P-01377 | 33% | S11 | AD-05 | no change | 42 |
| P-01483 | 33% | S14 | AD-05 | no change | 35 |
| P-01773 | 28% | S05 | AD-05 | improved | 27 |
| P-01350 | 35% | S19 | BR-03 | no change | 34 |
| P-01689 | 33% | S13 | BR-03 | no change | 50 |
| P-01313 | 30% | S01 | BR-03 | improved | 32 |
| P-01468 | 29% | S06 | BR-03 | no change | 41 |
| P-01450 | 28% | S09 | BR-03 | no change | 36 |
| P-01430 | 44% | S05 | CR-01 | improved | 54 |